AKT1 and neuroblastoma: Retinoic acid, described to protect against proteasome inhibition-associated cell death in neuroblastoma cells via the survival protein kinase B (AKT) pathway [128], has been used as an add-on with antipsychotic treatment and showed a significant reduction of positive symptoms in SZ patients [129].